Source:http://linkedlifedata.com/resource/pubmed/id/16141680
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2005-9-5
|
pubmed:abstractText |
Cardiac injury, occurred after traumatic brain injury (TBI), has been recognized for more than a century. Bcl-2 is a key regulatory component of the mitochondrial cell death pathway, and its overexpression is cytoprotective in many cell types. The therapeutic agents, which induce the expression of bcl-2 protein, might provide a new therapy to prevent cardiac myocyte damage following TBI. In this study, we investigated whether methylprednisolone sodium succinate (MPSS) influences the expression of bcl-2 in the heart. Wistar-Albino female rats underwent TBI (300 g/cm) generated by the weight-drop method, and were left untreated (n = 6) or treated with either MPSS (30 mg/kg) (n = 6) or vehicle (albumin solution) (n = 6). The heart was isolated from each animal with TBI. For comparison, the hearts were isolated from sham-operated (n = 6) and control rats (n = 6). The relative expression of bcl-2 mRNA in the heart was quantitated by real-time polymerase chain reaction. We also assessed lipid peroxidation in the heart tissue by determining the concentration of thiobarbituric acid-reactive substances (TBARs) as an indicator of tissue damage. The bcl-2 expression level was significantly higher in the hearts of MPSS-treated rats compared to that of other TBI groups (p < 0.0001). Moreover, TBI increased the lipid peroxidation in the heart, which was significantly reduced by the treatment with MPSS (p < 0.0001). These findings provide evidence for the efficacy of MPSS in protection of cardiac myocytes to achieve optimal heart donation after TBI in heart transplantation.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Methylprednisolone Hemisuccinate,
http://linkedlifedata.com/resource/pubmed/chemical/Neuroprotective Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Proto-Oncogene Proteins c-bcl-2,
http://linkedlifedata.com/resource/pubmed/chemical/RNA, Messenger,
http://linkedlifedata.com/resource/pubmed/chemical/Thiobarbituric Acid Reactive...
|
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0040-8727
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
207
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
119-24
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:16141680-Animals,
pubmed-meshheading:16141680-Apoptosis,
pubmed-meshheading:16141680-Brain Injuries,
pubmed-meshheading:16141680-Disease Models, Animal,
pubmed-meshheading:16141680-Female,
pubmed-meshheading:16141680-Lipid Peroxidation,
pubmed-meshheading:16141680-Methylprednisolone Hemisuccinate,
pubmed-meshheading:16141680-Myocytes, Cardiac,
pubmed-meshheading:16141680-Neuroprotective Agents,
pubmed-meshheading:16141680-Proto-Oncogene Proteins c-bcl-2,
pubmed-meshheading:16141680-RNA, Messenger,
pubmed-meshheading:16141680-Rats,
pubmed-meshheading:16141680-Rats, Wistar,
pubmed-meshheading:16141680-Thiobarbituric Acid Reactive Substances
|
pubmed:year |
2005
|
pubmed:articleTitle |
Beneficial effect of methylprednisolone on cardiac myocytes in a rat model of severe brain injury.
|
pubmed:affiliation |
Department of Cardiovascular Surgery, TYIH, Ankara, Turkey.
|
pubmed:publicationType |
Journal Article,
Comparative Study
|